Form 4 for LLY Lilly (Eli)
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0000059478-23-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-10 | LLY | Pusey Leigh Ann | EVP, Corp. Affairs, Comm | A - Grant | $345.12 | +3,681 | 31.6K | +13% | +$1.27M |
| D | 2023-02-14 | 2023-02-10 | LLY | Pusey Leigh Ann | EVP, Corp. Affairs, Comm | A - Grant | $0.00 | +1,744 | 1,744 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | A | A | 3,681 | $345.12 | 31,641 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2023-02-10 | A | A | 1,744 | $0.00 | 1,744 | D | — · 2024-02-01 to 2024-02-01 | 1,744 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |